ClinicalTrials.Veeva

Menu

An Application That Can Provide Early Warning of Temperature Health Risks and Give Protective Suggestions or Personalized Suggestions Based on Patients' Own Secondary Prevention Risk Factors Was Applied to Intervene, and the Intervention Effect of APP on Stroke Recurrence Risk Was Analyzed

Capital Medical University logo

Capital Medical University

Status

Not yet enrolling

Conditions

Acute Ischemic Stroke

Treatments

Other: Temperature health risk early warning
Other: Individualized temperature health risk early warning and risk factor management
Other: Risk factor management

Study type

Interventional

Funder types

Other

Identifiers

NCT06904664
[2024]444-003-1-3

Details and patient eligibility

About

This study employs individualized temperature health risk early warning and risk factor management interventions for stroke, and explores their actual intervention effects. This enables patients to promptly understand their own risk levels and take corresponding protective measures, thereby enhancing the management outcomes and quality of life. The study also promotes the interdisciplinary integration of environmental epidemiology and clinical intervention management, providing new ideas and methodological support for future relevant research.

Enrollment

10,184 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 40 to 80, with no gender restrictions;

    • Acute ischemic stroke inpatients within 2 weeks of onset, where the onset time is the time when stroke symptoms appear or the last known normal time of the patient (when it is an onset during sleep or the symptom onset time cannot be accurately obtained due to aphasia, impaired consciousness, etc.); ③ Confirmed diagnosis of ischemic stroke by CT or MRI of the brain within 2 weeks after symptom onset;

      • Local residents (residing for ≥6 months); ⑤ Patients who voluntarily participate in the study, have high compliance, and can sign the informed consent form;

        • Patients who own a smartphone or other smart devices.

Exclusion criteria

  • Patients diagnosed with other cerebrovascular diseases (hemorrhagic stroke, transient ischemic attack, cerebral venous sinus thrombosis, etc.) or non-cerebrovascular diseases;

    • Known pregnant or lactating women, or those who tested positive on a pregnancy test before cluster randomization;

      • Patients with other conditions that may affect participation in the trial (e.g., refractory hypertension, severe aphasia, etc.);

        • Patients undergoing psychiatric/psychological treatment that may contaminate the results; ⑤ Patients with a life expectancy of less than one year (e.g., coexisting malignant tumors, severe cardiopulmonary diseases, etc.); ⑥ Patients already participating in other interventional clinical studies that may influence the outcome assessment; ⑦ Patients for whom the investigator deems unsuitable for participation in this study or who may pose significant risks to the patients (e.g., cognitive impairment preventing understanding and/or compliance with the study procedures and/or follow-up).

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

10,184 participants in 4 patient groups

Enhanced intervention group
Experimental group
Description:
Receive individualized temperature health risk warning and prevention risk factor management information for stroke through the application
Treatment:
Other: Individualized temperature health risk early warning and risk factor management
Temperature health risk early warning group
Experimental group
Description:
Receive individualized temperature health risk warning through the application
Treatment:
Other: Temperature health risk early warning
Risk factor management group
Experimental group
Description:
Receive individualized prevention risk factor management information for stroke through the application
Treatment:
Other: Risk factor management
Routine education group
No Intervention group
Description:
Only receive routine health education, without receiving individualized temperature health risk warning or prevention risk factor management information for stroke through the application

Trial contacts and locations

0

Loading...

Central trial contact

Junwei Hao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems